Help
Subscribe


Submit Videos to GastroHep Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Endoscopic treatment vs surgery for the survival of esophageal cancer

November's issue of the Clinical Gastroenterology & Hepatology examines the survival of patients with superficial esophageal adenocarcinoma after endoscopic treatment vs surgery.

News image

Endoscopic therapy can improve long-term outcomes of patients with superficial esophageal adenocarcinoma, producing fewer complications than esophagectomy.

However, there have been few population-based studies to compare long-term outcomes of patients who received these treatments.

Dr Michael Wallace and colleagues from Florida, USA used a large national cancer database to evaluate the outcomes of patients with superficial esophageal adenocarcinoma who underwent endoscopic therapy or surgery.

The research team used the Surveillance Epidemiology and End Results database to identify 1618 patients with Tis or T1 N0M0 esophageal adenocarcinoma from 1998–2009.

Patients were grouped on the basis of whether they received endoscopic therapy or surgery.

Multivariate logistic regression was performed to identify factors associated with endoscopic therapy.

The researchers collected survival data through the end of 2009.

Overall survival after 5 years was higher in the surgery group
Clinical Gastroenterology & Hepatology

Overall survival and esophageal cancer–specific survival were compared after controlling for relevant covariates.

The researchers observed that the use of endoscopic therapy increased progressively from 3% in 1998 to 29% in 2009.

The team noted that factors associated with use of endoscopic therapy included age older than 65 years, diagnosis in 2006−2009 vs 1998−2001, and the absence of submucosal invasion.

The research team noted that overall survival after 5 years was higher in the surgery group than in the endoscopic therapy group.

After adjusting for patient and tumor factors, patients treated by endoscopy had similar overall survival times, and esophageal cancer–specific survival times.

Dr Wallace's team concluded, "In a population-based analysis, the use of endoscopic therapy for superficial esophageal adenocarcinoma tended to increase from 1998–2009."

"Long-term survival of patients with esophageal adenocarcinoma did not appear to differ between those who received endoscopic therapy and those treated with surgery."

Clin Gastroenterol Hepatol 2013: 11(11): 1424-1429.e2
30 October 2013

Go to top of page Email this page Email this page to a colleague

 21 October 2014

Advanced search
 21 October 2014 
Scoring systems for critically ill cirrhotic patients
 21 October 2014 
Aspirin and NAFLD
 21 October 2014 
Alcohol and Barrett's
 20 October 2014 
Drug resistant H pylori eradication
 20 October 2014 
Adalimumab in secondary loss of response in Crohn's
 20 October 2014 
Omega-3 and colorectal cancer
 17 October 2014 
Colorectal testing utilization
 17 October 2014 
Fecal microbiota composition in postinfectious IBS
 17 October 2014 
Tumor necrosis factor-alpha inhibitors and pregnancy in IBD
 16 October 2014 
Risk of Barrett's esophagus
 16 October 2014 
Aspirin tablets and colorectal tumours
 16 October 2014 
Economic impact of IBS
 15 October 2014 
Achieving competency at colonoscopy
 15 October 2014 
Preparation for surgery in Crohn's
 15 October 2014 
Bowel preparations
 14 October 2014 
Colorectal testing utilization in commercially insured US adults
 14 October 2014 
Sustained response to infliximab
 14 October 2014 
IBD management during pregnancy
 13 October 2014 
Predicting PPI response in GERD-related cough
 13 October 2014 
Probiotics in IBS
 13 October 2014 
Use of azathioprine in IBD
 10 October 2014 
NAFLD in the Veterans Administration population
 10 October 2014 
Liver injury from herbals and dietary supplements
 10 October 2014 
Predictors for cecal insertion time
 09 October 2014 
Methotrexate-related liver disease and metabolic syndrome
 09 October 2014 
Biomarkers of acetaminophen overdose patients
 09 October 2014 
Postoperative adhesions in digestive surgery
 08 October 2014 
Feeding intervention in celiac disease infants
 08 October 2014 
Gluten introduction in high risk children
 08 October 2014 
Vitamin D and HCC
 07 October 2014 
Infliximab in pediatric perianal Crohn's
 07 October 2014 
Omega-3 and NAFLD
 07 October 2014 
Endoscopic submucosal dissection in the colorectum 
 06 October 2014 
Clinical indications for computed tomographic colonography
 06 October 2014 
Certolizumab pegol in the treatment of Crohn's
 06 October 2014 
Costs of telaprevir therapy for Hep C
 03 October 2014 
Depression and liver transplantation
 03 October 2014 
Orange juice intake during bowel preparation
 03 October 2014 
HCV and diabetes
 02 October 2014 
Predictive model of Hep C disease progression
 02 October 2014 
IPAA with or without preoperative radiation
 02 October 2014 
Person-to-person transmission of norovirus
 01 October 2014 
Prevention of postop Crohn's
 01 October 2014 
Cecal intubation time during colonoscopy
 01 October 2014 
Anti-TNFa therapies during pregnancy in IBD
 30 September 2014 
Autoimmune hepatitis
 30 September 2014 
Medication use in patients with chronic Hep C
 30 September 2014 
Gastric cancer according to H pylori infection status
 29 September 2014 
Drug exposure and microscopic colitis
 29 September 2014 
Peptic ulcer bleeding after PPI treatment
 29 September 2014 
Intestinal tuberculosis vs Crohn's disease
 26 September 2014 
5-aminosalicylates for the treatment of Crohn's
 26 September 2014 
Response to infliximab in paediatric perianal Crohn's
 26 September 2014 
Ondansetron for IBS with diarrhea
 25 September 2014 
Medical treatment and surgery rates in IBD
 25 September 2014 
Liver transplants for liver cancer
 25 September 2014 
Colorectal neoplasia among family members of patients with colorectal cancer
 24 September 2014 
Health services burden of IBD
 24 September 2014 
PPIs after antireflux surgery
 24 September 2014 
Antidepressants in chronic liver disease

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2014 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us